Cargando…
Potential therapeutic targets for sarcopenia identified by Mendelian randomisation
BACKGROUND: Identifying sarcopenia’s causally associated plasma proteins would provide potential therapeutic targets. METHODS: We screened out sarcopenia-related proteins with genome-wide association studies (GWAS) summary data and cis-protein loci genetic instruments. Summary data of sarcopenia wer...
Autores principales: | Jiang, Wei, Zhan, Wenli, Zhou, Luoqi, Dong, Minghao, Liu, Liang, Xu, Xiangshang, Cao, Zhixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949583/ https://www.ncbi.nlm.nih.gov/pubmed/36821647 http://dx.doi.org/10.1093/ageing/afad024 |
Ejemplares similares
-
Correction to: Potential therapeutic targets for sarcopenia identified by Mendelian randomisation
Publicado: (2023) -
CT-determined sarcopenia is associated with neutropenia in patients undergoing hyperthermic intraperitoneal chemotherapy for gastrointestinal cancer
por: Jiang, Wei, et al.
Publicado: (2023) -
Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease
por: Su, Wei-Ming, et al.
Publicado: (2023) -
Putative Candidate Drug Targets for Sarcopenia-Related Traits Identified Through Mendelian Randomization Analysis of the Blood Proteome
por: Chen, Bin-Bin, et al.
Publicado: (2022) -
Research progress on the intrinsic non-immune function of PD-L1 in tumors (Review)
por: Deng, Jiao, et al.
Publicado: (2022)